Clinical Trials Support Services MarketSize and Trends

The global clinical trials support services market was valued at US$ 20.84 Bn in 2022 and is forecast to reach a value of US$ 37.13 Bn by 2030 at a CAGR of 7.5% between 2023 and 2030. The global clinical trials support services market is experiencing strong growth owing to the increasing demand for clinical trials support services and rise in burden of chronic and infectious disease. Furthermore, increasing number of clinical trials and increase in drug discovery and drug development is expected to boost the market growth. However, factors such as stringent regulatory framework and poor healthcare infrastructure are expected to hamper the market growth.

Global Clinical Trials Support Services Market: Regional Insights

Based on geography, the global clinical trials support services market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

Among regions, North America is expected to gain highest share in the market during the forecast period owing to the increasing prevalence of orphan and rare disease, increasing demand for safe and effective treatment, high cost of in-house drug development (

Global Clinical Trials Support Services Market: Key Companies Insights

The global clinical trials support services market is highly competitive, and this is attributed to the increasing number of clinical trials across the globe, as a result, players in the market are focusing on launching novel products in the market.

Some of the key players in the global clinical trials support services market are Wuxi AppTec, Inc., IQVIA Holdings, Inc., Syneos Health, Inc., Eurofins Scientific, Laboratory Corporation of America Holdings (Labcorp), Icon PLC, ALCURA, Parexel International Corporation, PPD, Inc. (Pharmaceutical Product Development), and Charles River Laboratories International, Inc.

)